Combination of MDR modulators and GCS inhibitor synergistically induce cytotoxicity in various human solid tumor cell lines, including neuroblastoma and melanoma, prostate, lung, colon, breast, and pancreatic cancers [177]. The gene discussed is UGCG; the disease is melanoma.